V.SBM
|
I have to agree with MWM. On the occasion of the AbbVie deal, Howie already...
|
V.SBM
|
Sorry, but this private placement is or was a bad joke. It took this...
|
V.SBM
|
No new brand registration. Ascentiv and Illumid have been...
|
V.SBM
|
Transperance wrote: biorun, 1 You stated that "Linda Pullen said it was...
|
V.SBM
|
I really wonder what we can expect from this Q&A event. The management...
|
V.SBM
|
navajojoe wrote: That is what I was afraid of, the 14.5 bid was bs, and they...
|
V.SBM
|
MirrorWorldMan wrote: This only discusses Lyteria 2.0 pigment correction...
|
V.SBM
|
SironaInvestor wrote: Absolutely!!! I'm so excited about Sirona's...
|
V.SBM
|
bealert wrote: You are right SironaInvestor, I should be a little more...
|
V.SBM
|
Pareto8020 wrote: Hopefully they can deliver on something b4 year end cause I...
|
V.SBM
|
lscfa wrote: Vote your disgust there. I could puke! Reminds me of 2017...
|
V.SBM
|
... there are still some other AH companies left which may license in...
|
V.SBM
|
jimmyhorizon wrote: Bought 1500 shares with limit 0.13 CAD to support the...
|
V.SBM
|
Turtle4 wrote: Abbvie conducted a very long and intensive due diligence. And...
|
V.SBM
|
Turtle4 wrote: Easy question: Abbvie will not make an offer, because they...
|
V.SBM
|
forhandlaren wrote: I don't think they actually want to sell the shares...
|
V.SBM
|
...is finally a share price >= 1$. That's all I want (oh, and I don...
|
V.SBM
|
Tickel1st wrote: Bee Alert. I don't think he is going to report it. At...
|
V.SBM
|
Pareto8020 wrote: This is like watching a super slow-mo train wreck (years in...
|
V.SBM
|
Tickel1st wrote: ..I'm wondering if our CEO is ready to do an open door...
|